These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6447614)

  • 1. Trypanosoma rhodesiense: semiautomated microtesting for quantitation of antitrypanosomal activity in vitro.
    Desjardins RE; Casero RA; Willet GP; Childs GE; Canfield CJ
    Exp Parasitol; 1980 Oct; 50(2):260-71. PubMed ID: 6447614
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of 2-acetylpyridine thiosemicarbazones against Trypanosoma rhodesiense in vitro.
    Casero RA; Klayman DL; Childs GE; Scovill JP; Desjardins RE
    Antimicrob Agents Chemother; 1980 Aug; 18(2):317-22. PubMed ID: 7447409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth rates of suramin-sensitive and resistant Trypanosoma evansi.
    Mutugi MW; Boid R; Luckins AG
    Trop Anim Health Prod; 1996 May; 28(2):147-50. PubMed ID: 8809977
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug effects on the fine structure of Trypanosoma rhodesiense: suramin, tryparsamide and mapharside.
    Macadam RF; Williamson J
    Ann Trop Med Parasitol; 1974 Sep; 68(3):301-6. PubMed ID: 4280885
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro antitrypanosomal activity of plant terpenes against Trypanosoma brucei.
    Otoguro K; Iwatsuki M; Ishiyama A; Namatame M; Nishihara-Tukashima A; Kiyohara H; Hashimoto T; Asakawa Y; Omura S; Yamada H
    Phytochemistry; 2011 Nov; 72(16):2024-30. PubMed ID: 21843897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanosoma evansi: measurement of pyruvate production as an indicator of the drug sensitivity of isolates in vitro.
    Sutherland DV; Barns AM; Ross CA
    Trop Med Parasitol; 1995 Jun; 46(2):93-8. PubMed ID: 8525292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of Trypanosoma evansi to quinapyramine, suramin, stilbamidine and tryparsamide and analysis of cross-resistance.
    Gill BS
    Trans R Soc Trop Med Hyg; 1971; 65(3):352-7. PubMed ID: 4254332
    [No Abstract]   [Full Text] [Related]  

  • 8. [In vivo resistance to strains of Trypanosoma rhodesiense, Mozambique, 1985].
    Pérez Martín O; Lastre González M; Urban M; Shwalbach J
    Rev Cubana Med Trop; 1991; 43(3):189-93. PubMed ID: 9768188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A trypanosome oligopeptidase as a target for the trypanocidal agents pentamidine, diminazene and suramin.
    Morty RE; Troeberg L; Pike RN; Jones R; Nickel P; Lonsdale-Eccles JD; Coetzer TH
    FEBS Lett; 1998 Aug; 433(3):251-6. PubMed ID: 9744805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mobility variation as a criterion of antitrypanosomal activity in vitro and potentiation of antimonials by serum.
    Olivo N; Ercoli N
    Acta Cient Venez; 1976; 27(3):129-31. PubMed ID: 1020600
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro effects of suramin on Trypanosoma cruzi.
    Bisaggio DF; Adade CM; Souto-Padrón T
    Int J Antimicrob Agents; 2008 Mar; 31(3):282-6. PubMed ID: 18191547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitrypanosomal activity of quaternary naphthalimide derivatives.
    Muth M; Hoerr V; Glaser M; Ponte-Sucre A; Moll H; Stich A; Holzgrabe U
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1590-3. PubMed ID: 17239596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitrypanosomal effects of traditional Chinese herbal medicines on bloodstream forms of Trypanosoma brucei rhodesiense in vitro.
    Yabu Y; Nose M; Koide T; Ohta N; Ogihara Y
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):599-604. PubMed ID: 10437965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine structural alterations in Trypanosoma rhodesiense grown in vitro, treated with WR 163577.
    Berman JD; Oka M; Aikawa M
    J Protozool; 1984 Feb; 31(1):184-6. PubMed ID: 6547485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate lack of susceptibility of Ugandan Trypanosoma brucei rhodesiense to DL-alpha-difluoromethylornithine (DFMO).
    Iten M; Matovu E; Brun R; Kaminsky R
    Trop Med Parasitol; 1995 Sep; 46(3):190-4. PubMed ID: 8533023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Arylpaullones are selective antitrypanosomal agents.
    Ryczak J; Papini M; Lader A; Nasereddin A; Kopelyanskiy D; Preu L; Jaffe CL; Kunick C
    Eur J Med Chem; 2013 Jun; 64():396-400. PubMed ID: 23648975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic variation in clones of Trypanosoma brucei. II. The drug-sensitivities of variants of a clone and the antigenic relationships of trypanosomes before and after drug treatment.
    Gray AR
    Ann Trop Med Parasitol; 1966 Sep; 60(3):265-75. PubMed ID: 4226334
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of trypanocidal drugs on DNA synthesis: new insights into melarsoprol growth inhibition.
    Larson S; Carter M; Hovel-Miner G
    Parasitology; 2021 Sep; 148(10):1143-1150. PubMed ID: 33593467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to drug by different isolates Trypanosoma evansi in China.
    Zhou J; Shen J; Liao D; Zhou Y; Lin J
    Acta Trop; 2004 May; 90(3):271-5. PubMed ID: 15099814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. THE SELECTIVE ACTION IN CULTURE OF SOME TRYPANOCIDAL DRUGS ON TRYPANOSOMA RHODESIENSE AND T. BRUCEI.
    LEHMANN DL
    Ann Trop Med Parasitol; 1964 Jun; 58():189-91. PubMed ID: 14183105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.